Home
Inanovate Spotlight
Image

Comming soon: The i-Chip™ and i-Slide™ substrate platforms.      "The best surfaces in the world for handling and working with proteins".   50% introductory discount offer!
 

Our Mission

Inanovate's mission is to make accurate cancer screening available and affordable to everyone.

To achieve this mission, Inanovate combines proprietary nano-scale surface technologies, protein screening procedures, and protein biomarker content, with cutting edge expertise and facilities; to create advanced biochip systems for handling and working with proteins.

Products & Services

In addition to the development of clinical diagnostic systems, Inanovate offers a range of pre-clinical products and services designed to make protein biochip based research more accurate, more reliable and more cost effective. Our offerings include: The leading surfaces in the world for handling and working with proteins; Unique and powerful biomarker screening procedures; and a variety of services including protein printing/arraying, and assay development.

Read more

Our History

Inanovate was founded in 2005 by David Ure and David Arslanian. The company grew on a foundation provided by a unique nano-scale surface fabrication technology developed at the Nano-Scale Physics Research Laboratory at the University of Birmingham (UK). This novel approach to surface fabrication led to Inanovate’s first product, a protein biochip substrate platform called the i-Chip™

Read More

The i-Screen

A low cost, disposable, diagnostic platform for the early detection and monitoring of cancer at the point of care. The i-Screen™ is designed to move the healthcare industry’s focus away from expensive, painful and often ineffective late stage cancer treatment, towards early stage diagnosis and lower impact, lower cost therapies.

Read More

The i-Chip

Using proprietary nano-scale surface patterning technology, Inanovate has developed the leading surfaces in the world for handling and working with proteins. The i-Chip™ covalently attaches proteins to a surface, controlling their densities, influencing their orientations, helping maintain their function, and thus optimizing assay performance. The i-Chip™ provides the ultimate in protein biochip technology for researchers requiring industry leading sensitivity, consistency and reproducibility.

Read More

The i-Assay

Inanovate owns exclusive rights to a unique method of biomarker discovery, developed at Harvard Medical School, and based on a proprietary reverse capture assay procedure for the rapid and accurate screening of auto-antibody biomarkers. Inanovate has developed this system into a sophisticated biomarker screening platform called the i-Assay™.

Read More

The i-Slide

The i-Slide™ uses a proprietary nano-structured surface architecture to non-specifically attach proteins to a surface in a controlled and consistent way; providing protein researchers with high end substrate performance at industry leading prices.

Read More